Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates the pituitary signaling pathway involved in growth hormone release. At Weight Loss Clinic Los Angeles, peptide-related questions are approached through a comprehensive physician evaluation rather than a one-size-fits-all peptide protocol.
Sermorelin acts on the growth hormone-releasing hormone receptor and is different from taking growth hormone itself. A sermorelin product was previously FDA approved for pediatric growth hormone deficiency; FDA records indicate the approvals for products containing sermorelin were withdrawn in 2009 after manufacturing was discontinued. This history does not mean sermorelin is FDA approved today for anti-aging, body composition, weight loss, or general wellness.
Sermorelin and CJC-1295 are related to GHRH signaling, while ipamorelin acts through the ghrelin/growth-hormone secretagogue receptor. They should not be treated as interchangeable. Evidence, regulatory status, formulation, potential adverse effects, and patient-specific risks differ. Read our CJC-1295 and Ipamorelin guide and our main Peptide Therapy Los Angeles overview.
Symptoms such as fatigue, reduced exercise performance, changes in body composition, poor sleep, or difficulty managing weight can have many causes. A comprehensive evaluation can include medical history, medications, sleep and lifestyle factors, physical findings, and laboratory testing when clinically appropriate. Treatment should be directed at identified problems rather than assuming a peptide is the appropriate answer.
No. Sermorelin should not be represented as an FDA-approved weight-loss treatment.
No. Sermorelin is related to GHRH signaling and stimulates pituitary growth-hormone release; it is not recombinant human growth hormone.
Claims about body composition, recovery, anti-aging, or weight loss should be interpreted cautiously because those uses are not FDA-approved indications for sermorelin. Individual treatment decisions require medical assessment.
Explore Tesamorelin, BPC-157, Peptides & Metabolic Health, and Medical Weight Loss.
The initial comprehensive physician evaluation is $450. Follow-up physician visits are $250. Testing and treatment recommendations depend on individual medical needs.
